181 related articles for article (PubMed ID: 15331067)
1. Tumor necrosis factor and its potential role in insulin resistance and nonalcoholic fatty liver disease.
Diehl AM
Clin Liver Dis; 2004 Aug; 8(3):619-38, x. PubMed ID: 15331067
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of disease: adipocytokines and visceral adipose tissue--emerging role in nonalcoholic fatty liver disease.
Schäffler A; Schölmerich J; Büchler C
Nat Clin Pract Gastroenterol Hepatol; 2005 Jun; 2(6):273-80. PubMed ID: 16265231
[TBL] [Abstract][Full Text] [Related]
3. Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway.
Feldstein AE; Werneburg NW; Canbay A; Guicciardi ME; Bronk SF; Rydzewski R; Burgart LJ; Gores GJ
Hepatology; 2004 Jul; 40(1):185-94. PubMed ID: 15239102
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-10 to tumor necrosis factor-alpha ratio is a predictive biomarker in nonalcoholic fatty liver disease: interleukin-10 to tumor necrosis factor-alpha ratio in steatohepatitis.
Hashem RM; Mahmoud MF; El-Moselhy MA; Soliman HM
Eur J Gastroenterol Hepatol; 2008 Oct; 20(10):995-1001. PubMed ID: 18787467
[TBL] [Abstract][Full Text] [Related]
5. Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease.
Li Z; Soloski MJ; Diehl AM
Hepatology; 2005 Oct; 42(4):880-5. PubMed ID: 16175608
[TBL] [Abstract][Full Text] [Related]
6. Nonalcoholic fatty liver disease as a complication of insulin resistance.
Abdelmalek MF; Diehl AM
Med Clin North Am; 2007 Nov; 91(6):1125-49, ix. PubMed ID: 17964913
[TBL] [Abstract][Full Text] [Related]
7. Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with Adult Treatment Panel III criteria in nonobese nondiabetic subjects.
Musso G; Gambino R; Bo S; Uberti B; Biroli G; Pagano G; Cassader M
Diabetes Care; 2008 Mar; 31(3):562-8. PubMed ID: 18056890
[TBL] [Abstract][Full Text] [Related]
8. Novel insights into the pathophysiology of nonalcoholic fatty liver disease.
Feldstein AE
Semin Liver Dis; 2010 Nov; 30(4):391-401. PubMed ID: 20960378
[TBL] [Abstract][Full Text] [Related]
9. Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease.
Parekh S; Anania FA
Gastroenterology; 2007 May; 132(6):2191-207. PubMed ID: 17498512
[TBL] [Abstract][Full Text] [Related]
10. Nonalcoholic fatty liver disease.
Angulo P
Rev Gastroenterol Mex; 2005 Nov; 70 Suppl 3():52-6. PubMed ID: 17471859
[TBL] [Abstract][Full Text] [Related]
11. Hepatic triglyceride synthesis and nonalcoholic fatty liver disease.
Choi SS; Diehl AM
Curr Opin Lipidol; 2008 Jun; 19(3):295-300. PubMed ID: 18460922
[TBL] [Abstract][Full Text] [Related]
12. Interaction of metabolic syndrome, nonalcoholic fatty liver disease and chronic hepatitis C.
Rafiq N; Younossi ZM
Expert Rev Gastroenterol Hepatol; 2008 Apr; 2(2):207-15. PubMed ID: 19072356
[TBL] [Abstract][Full Text] [Related]
13. Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis.
Wieckowska A; Papouchado BG; Li Z; Lopez R; Zein NN; Feldstein AE
Am J Gastroenterol; 2008 Jun; 103(6):1372-9. PubMed ID: 18510618
[TBL] [Abstract][Full Text] [Related]
14. Insulin resistance and the pathogenesis of nonalcoholic fatty liver disease.
Choudhury J; Sanyal AJ
Clin Liver Dis; 2004 Aug; 8(3):575-94, ix. PubMed ID: 15331065
[TBL] [Abstract][Full Text] [Related]
15. Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery.
Verna EC; Berk PD
Semin Liver Dis; 2008 Nov; 28(4):407-26. PubMed ID: 18956297
[TBL] [Abstract][Full Text] [Related]
16. Genetics of alcoholic liver disease and nonalcoholic fatty liver disease.
Wilfred de Alwis NM; Day CP
Semin Liver Dis; 2007 Feb; 27(1):44-54. PubMed ID: 17295176
[TBL] [Abstract][Full Text] [Related]
17. Nonalcoholic fatty liver disease in severely obese subjects.
Gholam PM; Flancbaum L; Machan JT; Charney DA; Kotler DP
Am J Gastroenterol; 2007 Feb; 102(2):399-408. PubMed ID: 17311652
[TBL] [Abstract][Full Text] [Related]
18. Nonalcoholic fatty liver disease: hepatic manifestation of obesity and the metabolic syndrome.
Boppidi H; Daram SR
Postgrad Med; 2008 Jul; 120(2):E01-7. PubMed ID: 18654060
[TBL] [Abstract][Full Text] [Related]
19. The role of the lipogenic pathway in the development of hepatic steatosis.
Postic C; Girard J
Diabetes Metab; 2008 Dec; 34(6 Pt 2):643-8. PubMed ID: 19195625
[TBL] [Abstract][Full Text] [Related]
20. Nonalcoholic fatty liver disease and low-carbohydrate diets.
York LW; Puthalapattu S; Wu GY
Annu Rev Nutr; 2009; 29():365-79. PubMed ID: 19575599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
